Long-term carvedilol therapy in patients with stage II arterial hypertension
In total, 30 patients with Stage II arterial hypertension, AH (ESH/ESC 2003; Society of Cardiology of the Russian Federation 2004), mean age 51. 93 ± 7.96years. For 6 months, participants received carvedilol (Talliton, Hungary, Egis) in daily dose 25-75 mg. Microcirculation, hemorheology, and lipid...
Main Authors: | L. I. Markova, A. E. Radzevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2006-06-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1841 |
Similar Items
-
HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: L. I. Markova, et al.
Published: (2016-01-01) -
ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
by: V. A. Nevzorova, et al.
Published: (2016-01-01) -
Ramipril effects on cerebral blood flow and microcirculation in patients with essential arterial hypertension
by: L. I. Markova, et al.
Published: (1970-01-01) -
Clinical assessment of vasodilating carvedilol effects in patients with arterial hypertension and overweight/obesity: CAMELIA Study results
by: L. A. Sokolova, et al.
Published: (1970-01-01) -
Carvedilol monotherapy and lifestyle modification among young patients with arterial hypertension and overweight/obesity in primary healthcare settings
by: G. I. Nechaeva, et al.
Published: (2010-12-01)